×
About 6,421 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  2,475 results

Characteristics and Long -Term Outcomes of Patients Hospitalized for Diabetic Ketoacido...
https://doi.org/10.1002/dmrr.3408
Diabetes/metabolism Research and Reviews; Michaelis M, Shochat T et. al.

Sep 17th, 2020 - Diabetic ketoacidosis (DKA) is an acute metabolic complication characterized by hyperglycemia, ketones in blood or urine, and acidosis. Assess the characteristics of patients hospitalized for DKA, identify triggers for DKA and evaluate the long-te...

Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings: role of su...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 16th, 2020 - The International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state 1, 2 provide comprehensive guidance for mana...

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults ...
https://doi.org/10.2337/dc20-0924
Diabetes Care; Peters AL, McGuire DK et. al.

Sep 15th, 2020 - To evaluate the incidence and risk factors for diabetic ketoacidosis (DKA) and related adverse events (AEs) in adults with type 1 diabetes treated with sotagliflozin adjunctive to insulin. Data from two identically designed, 52-week, randomized st...

The effect of diabetic ketoacidosis (DKA) and its treatment on clot microstructure: Are...
https://doi.org/10.3233/CH-200957
Clinical Hemorheology and Microcirculation; Pillai S, Davies G et. al.

Sep 14th, 2020 - Diabetic ketoacidosis (DKA) is a medical emergency with a high mortality rate and is associated with severe metabolic acidosis and dehydration. DKA patients have an increased risk of arterial and venous thromboembolism, however little is known abo...

Management of sodium-glucose cotransporter 2 inhibitors during the perioperative period...
https://doi.org/10.1177/1750458920948693
Journal of Perioperative Practice; Ge V, Subramaniam A et. al.

Sep 8th, 2020 - Current guidelines recommend withholding sodium-glucose cotransporter 2 inhibitors perioperatively due to concerns of euglycaemic diabetic ketoacidosis. However, such guidelines are largely based on case reports and small case series, many extrapo...

see more →

Guidelines  13 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycem...
https://cdn.ymaws.com/www.ispad.org/resource/resmgr/consensus_guidelines_2018_/11.diabetic_ketoacidosis_and.pdf

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

Management of hyperosmolar hyperglycaemic state in adults with diabetes.
https://doi.org/10.1111/dme.12757
Diabetic Medicine : a Journal of the British Diabetic Association; Scott AR, et. al.

May 19th, 2015 - Hyperglycaemic hyperosmolar state (HHS) is a medical emergency, which differs from diabetic ketoacidosis (DKA) and requires a different approach. The present article summarizes the recent guidance on HHS that has been produced by the Joint British...

ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglyce...
https://doi.org/10.1111/pedi.12165
Pediatric Diabetes; Wolfsdorf JI, Allgrove J et. al.

Jul 21st, 2014 - ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state.|2014|Wolfsdorf JI,Allgrove J,Craig ME,Edge J,Glaser N,|trends,adverse effects,blood,complications,drug therapy,therapy,blood,complicatio...

see more →

Drugs  657 results see all →

Clinicaltrials.gov  3,157 results

Characteristics and Long -Term Outcomes of Patients Hospitalized for Diabetic Ketoacido...
https://doi.org/10.1002/dmrr.3408
Diabetes/metabolism Research and Reviews; Michaelis M, Shochat T et. al.

Sep 17th, 2020 - Diabetic ketoacidosis (DKA) is an acute metabolic complication characterized by hyperglycemia, ketones in blood or urine, and acidosis. Assess the characteristics of patients hospitalized for DKA, identify triggers for DKA and evaluate the long-te...

Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings: role of su...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 16th, 2020 - The International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state 1, 2 provide comprehensive guidance for mana...

Pioglitazone - pioglitazone tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af863b9e-9646-3b1e-e053-2995a90ab93a

Sep 16th, 2020 - Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies ( 14) ]. Important Li...

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults ...
https://doi.org/10.2337/dc20-0924
Diabetes Care; Peters AL, McGuire DK et. al.

Sep 15th, 2020 - To evaluate the incidence and risk factors for diabetic ketoacidosis (DKA) and related adverse events (AEs) in adults with type 1 diabetes treated with sotagliflozin adjunctive to insulin. Data from two identically designed, 52-week, randomized st...

Glipizide - glipizide tablet, extended release-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8768e96d-7d51-4b7b-a639-52f9ca6d665f

Sep 15th, 2020 - Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exerc...

see more →

News  115 results

FDA panel rejects new empagliflozin indication for type 1 diabetes
https://www.mdedge.com/familymedicine/article/212282/diabetes/fda-panel-rejects-new-empagliflozin-indication-type-1?channel=39313
MDedge Endocrinology; Kerry Dooley Young

Nov 13th, 2019 - A Food and Drug Administration advisory panel voted 14-2 against recommending approval of a supplemental New Drug Application for empagliflozin (Jardiance) as an adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes.

Gastroparesis
https://www.mdedge.com/ccjm/article/205638/diabetes/gastroparesis?channel=258
Amos Lal, MD, Pantea Ebrahimpour, MD et. al.

Aug 1st, 2019 - To the Editor: We read with great pleasure the article by Sharayah et al about acute gastro­paresis in a patient with diabetic ketoacidosis. 1 However, in the case description, the authors reached a diagnosis of gastroparesis secondary to diabetic.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

Patients with higher HbA1c levels face greater risk for diabetic ketoacidosis
https://www.mdedge.com/fedprac/article/199487/diabetes/patients-higher-hba1c-levels-face-greater-risk-diabetic-ketoacidosis?channel=53
Doug Brunk

Apr 25th, 2019 - LOS ANGELES – Patients with poor glycemic control, especially those with a hemoglobin A1c (HbA1c) level of more than 9%, face an increased risk for developing diabetic ketoacidosis (DKA), results from a registry study have demonstrated. Dr.

Gastroparesis in a patient with diabetic ketoacidosis
https://www.mdedge.com/ccjm/article/197434/gastroenterology/gastroparesis-patient-diabetic-ketoacidosis?channel=162
Ahmad Muneer Sharayah, MD, Noor Hajjaj, MD et. al.

Apr 1st, 2019 - A 40-year-old man with type 1 diabetes mellitus and recurrent renal calculi presented to the emergency department with nausea, vomiting, and abdominal pain for the past day. He had been checking his blood glucose level regularly, and it had usuall.

see more →

Patient Education  4 results see all →